STXS
Stereotaxis Inc

2,045
Mkt Cap
$201.59M
Volume
364,721.00
52W High
$3.59
52W Low
$1.54
PE Ratio
-7.68
STXS Fundamentals
Price
$2.16
Prev Close
$2.21
Open
$2.17
50D MA
$2.34
Beta
1.05
Avg. Volume
618,944.10
EPS (Annual)
-$0.2976
P/B
31.40
Rev/Employee
$193,654.68
$193.14
Loading...
Loading...
News
all
press releases
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) delivered earnings and revenue surprises of +29.73% and +4.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
More News
News Placeholder
TransMedics (TMDX) Beats Q4 Earnings and Revenue Estimates
TransMedics (TMDX) delivered earnings and revenue surprises of +40.02% and +3.11%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·5d ago
News Placeholder
Beta Bionics, Inc. (BBNX) Reports Q4 Loss, Tops Revenue Estimates
Beta Bionics, Inc. (BBNX) delivered earnings and revenue surprises of +28.57% and +0.07%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·12d ago
News Placeholder
da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?
ISRG's da Vinci 5 begins international rollout, but pricing sensitivity, budgets, and reimbursement hurdles could slow adoption outside the United States.
Zacks·2mo ago
News Placeholder
Is ISRG's 20% Procedure Growth the New Normal or a Peak?
ISRG posts 20% Q3 procedure growth as da Vinci and Ion volumes accelerate, but investors question if product cycles and timing effects can sustain it.
Zacks·2mo ago
News Placeholder
From Hospitals to ASCs: Will Refurbished Xi Systems Broaden ISRG's Reach?
ISRG leverages refurbished Xi systems to reach cost-sensitive markets and expand access beyond hospitals.
Zacks·3mo ago
News Placeholder
STXS Secures FDA Approval for GenesisX to Broaden Surgical Robotics
Stereotaxis wins FDA clearance for GenesisX, a streamlined robotic system aimed at boosting hospital adoption and accelerating growth.
Zacks·4mo ago
News Placeholder
Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates
Stereotaxis (STXS) delivered earnings and revenue surprises of +50.00% and -13.21%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Misses Revenue Estimates
Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of 0.00% and -0.79%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
News Placeholder
Mettler-Toledo (MTD) Beats Q3 Earnings and Revenue Estimates
Mettler-Toledo (MTD) delivered earnings and revenue surprises of +4.99% and +3.84%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·4mo ago
<
1
2
...
>

Latest STXS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.